Clinical trial
Placebo Controlled Trial of Botulinum Toxin for Gastroparesis
NCT00372970 · Temple University, Other · Completed
Key facts
| NCT number | NCT00372970 |
|---|---|
| Title | Placebo Controlled Trial of Botulinum Toxin for Gastroparesis |
| Official title | Randomized Placebo-Controlled Double Blind Study of Botulinum Toxin Versus Placebo for the Treatment of Gastroparesis |
| Lead sponsor | Temple University, Other |
| Collaborators | American College of Gastroenterology |
| Status | Completed |
| Study type | Interventional |
| Conditions | Gastroparesis |
| Intervention type | Drug |
| Interventions | Botulinum toxin A, Placebo |
| Enrollment | 32 |
| Start date | Jul 1, 2003 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 7, 2006 |
| Last update posted | Jun 9, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: